Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Grossmann

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
Polish Journal of Pharmacology and Pharmacy|January 1, 1974
Pharmacological effects of compounds similar to prostaglandinsV Grossmann, J Jary, S Dolezal, et al.
The Journal of Cardiovascular Surgery|September 1, 1971
Surgical treatment of the aneurysms of the descending thoracic aorta. A study of 14 casesR J Jaen, V Grossmann, M A Ortega, et al.
Materia Medica Polona. Polish Journal of Medicine and Pharmacy|October 1, 1975
Sex differences in the fate of N-methyl-14C-pethidine in ratsV Chmelar, V Grossmann, J Hradil, et al.
Leukemia|December 5, 2012
STAT3 mutations are highly specific for large granular lymphocytic leukemiaA Fasan, W Kern, V Grossmann, et al.
Activitas Nervosa Superior|September 1, 1984
Is DH-ergotoxine the best gerontologicum from the ergot source? Experimental comparison with individual componentsV Grossmann, R Hrdina, J Jezek, et al.
The Journal of Cardiovascular Surgery|March 1, 1970
Complications in open heart surgery. Analysis of 350 patientsR Jaén, V Grossmann-Siegert, M A Ortega, et al.
Journal of Pharmacological and Toxicological Methods|December 1, 1996
Possible use of excretion of tubular epithelial cells for the study of the nephrotoxic effect of xenobioticsV Stĕtinová, F Trejtnar, J Kopecký, et al.
Ceskoslovenska Radiologie|December 1, 1987
[Scintigraphic visualization of experimental cardiomyopathy in dogs using 99mTc-hexylidenaminodiphosphonate (99mTc-AHDP)]F Duska, J Vizd'a, P Kafka, et al.
Leukemia|October 22, 2011
Deletion of the tumor-suppressor gene NF1 occurs in 5% of myeloid malignancies and is accompanied by a mutation in the remaining allele in half of the casesC Haferlach, V Grossmann, A Kohlmann, et al.
Leukemia|February 23, 2011
Molecular profiling of chronic myelomonocytic leukemia reveals diverse mutations in >80% of patients with TET2 and EZH2 being of high prognostic relevanceV Grossmann, A Kohlmann, C Eder, et al.
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Polish Journal of Pharmacology and Pharmacy|January 1, 1974
Pharmacological effects of compounds similar to prostaglandinsV Grossmann, J Jary, S Dolezal, et al.
The Journal of Cardiovascular Surgery|September 1, 1971
Surgical treatment of the aneurysms of the descending thoracic aorta. A study of 14 casesR J Jaen, V Grossmann, M A Ortega, et al.
Materia Medica Polona. Polish Journal of Medicine and Pharmacy|October 1, 1975
Sex differences in the fate of N-methyl-14C-pethidine in ratsV Chmelar, V Grossmann, J Hradil, et al.
Leukemia|December 5, 2012
STAT3 mutations are highly specific for large granular lymphocytic leukemiaA Fasan, W Kern, V Grossmann, et al.
Activitas Nervosa Superior|September 1, 1984
Is DH-ergotoxine the best gerontologicum from the ergot source? Experimental comparison with individual componentsV Grossmann, R Hrdina, J Jezek, et al.
The Journal of Cardiovascular Surgery|March 1, 1970
Complications in open heart surgery. Analysis of 350 patientsR Jaén, V Grossmann-Siegert, M A Ortega, et al.
Journal of Pharmacological and Toxicological Methods|December 1, 1996
Possible use of excretion of tubular epithelial cells for the study of the nephrotoxic effect of xenobioticsV Stĕtinová, F Trejtnar, J Kopecký, et al.
Ceskoslovenska Radiologie|December 1, 1987
[Scintigraphic visualization of experimental cardiomyopathy in dogs using 99mTc-hexylidenaminodiphosphonate (99mTc-AHDP)]F Duska, J Vizd'a, P Kafka, et al.
Leukemia|October 22, 2011
Deletion of the tumor-suppressor gene NF1 occurs in 5% of myeloid malignancies and is accompanied by a mutation in the remaining allele in half of the casesC Haferlach, V Grossmann, A Kohlmann, et al.
Leukemia|February 23, 2011
Molecular profiling of chronic myelomonocytic leukemia reveals diverse mutations in >80% of patients with TET2 and EZH2 being of high prognostic relevanceV Grossmann, A Kohlmann, C Eder, et al.
Pageof 6